Literature DB >> 4169362

The mechanism of appearance of immunoglobulin A in nasal secretions in man.

W T Butler, R D Rossen, T A Waldmann.   

Abstract

Experiments were done to investigate mechanisms of appearance of both 7 S and 11 S IgA in nasal secretions. Three IgA preparations, (a) 11 S IgA from nasal secretions, (b) 7 S IgA from homologous serum, and (c) 7 S IgA from autologous serum, were isolated, labeled, and injected intravenously into volunteers. The rate of disappearance from plasma and the extent and nature of their appearance in nasal secretions were examined in detail. After intravenous injection, 11 S IgA from nasal secretions disappeared rapidly from plasma. However, only negligible amounts of 11 S IgA were detected in nasal secretion, which suggested that rapid selective secretion of circulating 11 S IgA does not occur as a mechanism of IgA accumulation in nasal secretions. Both the homologous and autologous 7 S IgA preparations disappeared from plasma at a normal rate, and both appeared in nasal secretions unchanged in sedimentation behavior. The specific activity of IgA in nasal secretions, when related to the total IgA concentration, was about 30-fold less than that in serum. When related to only the 7 S IgA concentration of nasal secretions, the specific activity was about one-half that of serum. These studies are consistent with the following hypotheses: (a) circulating 7 S IgA is a source of part of the 7 S IgA found in nasal secretions. The remainder of the nasal secretion 7 S IgA may be synthesized locally in the tissues of the upper respiratory tract; (b) 11 S IgA in nasal secretions is not assembled from serum 7 S IgA components; and (c) 11 S IgA in nasal secretions is synthesized de novo in the tissues of the upper respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4169362      PMCID: PMC292941          DOI: 10.1172/JCI105678

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  SERUM PROTEINS AND ANTIBODY ACTIVITY IN HUMAN NASAL SECRETIONS.

Authors:  J S REMINGTON; K L VOSTI; A LIETZE; A L ZIMMERMAN
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  IDENTIFICATION OF THE ANTIVIRAL SUBSTANCES IN NASAL SECRETIONS.

Authors:  M S ARTENSTEIN; J A BELLANTI; E L BUESCHER
Journal:  Proc Soc Exp Biol Med       Date:  1964-11

3.  CHARACTERIZATION OF VIRUS NEUTRALIZING ANTIBODIES IN HUMAN SERUM AND NASAL SECRETIONS.

Authors:  J A BELLANTI; M S ARTENSTEIN; E L BUESCHER
Journal:  J Immunol       Date:  1965-03       Impact factor: 5.422

4.  The proteins in nasal secretion: a longitudinal study of the gammaA-globulin, gammaG-globulin, albumin, siderophilin, and total protein concentrations in nasal washings from adult male volunteers.

Authors:  R D Rossen; A L Schade; W T Butler; J A Kasel
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

5.  Studies on the proteins of human bronchial secretions.

Authors:  P L Masson; J F Heremans; J Prignot
Journal:  Biochim Biophys Acta       Date:  1965-12-16

6.  Neutralizing and hemagglutination-inhibiting activity of nasal secretions following experimental human infection with A2 influenza virus.

Authors:  R H Alford; R D Rossen; W T Butler; J A Kasel
Journal:  J Immunol       Date:  1967-04       Impact factor: 5.422

7.  Protective effect of antibody to parainfluenza type 1 virus.

Authors:  C B Smith; R H Purcell; J A Bellanti; R M Chanock
Journal:  N Engl J Med       Date:  1966-11-24       Impact factor: 91.245

8.  The role of nasal secretion and serum antibody in the rhinovirus common cold.

Authors:  T R Cate; R D Rossen; R G Douglas; W T Butler; R B Couch
Journal:  Am J Epidemiol       Date:  1966-09       Impact factor: 4.897

9.  Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism.

Authors:  R D Wochner; G Drews; W Strober; T A Waldmann
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

10.  Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies.

Authors:  E R Stiehm; J P Vaerman; H H Fudenberg
Journal:  Blood       Date:  1966-12       Impact factor: 22.113

View more
  32 in total

1.  Determination of immunoglobulin A concentrations in human nasal secretions with a serum immunoglobulin A standard.

Authors:  S B Greenberg; R D Rossen; H R Six; B D Baxter; R B Couch
Journal:  J Clin Microbiol       Date:  1978-10       Impact factor: 5.948

Review 2.  Immunoglobulins and the gut.

Authors:  E A Jones
Journal:  Gut       Date:  1972-10       Impact factor: 23.059

3.  Nasal immunoglobulin responses in acute rubella determined by the immunofluorescent technique.

Authors:  J E Cradock-Watson; M K Ridehalgh; M S Bourne; E M Vandervelde
Journal:  J Hyg (Lond)       Date:  1973-09

Review 4.  The demonstration and function of antibodies in the gastrointestinal tract.

Authors:  D J Shearman; D M Parkin; D B McClelland
Journal:  Gut       Date:  1972-06       Impact factor: 23.059

Review 5.  The significance of secretory immunoglobulins.

Authors:  J Bienenstock
Journal:  Can Med Assoc J       Date:  1970-07-04       Impact factor: 8.262

6.  An analysis of gastric parietal cell antibodies and thyroid cell antibodies in patients with pernicious anaemia and thyroid disorders.

Authors:  A Cruchaud; E Juditz
Journal:  Clin Exp Immunol       Date:  1968-10       Impact factor: 4.330

7.  Immunochemical analysis of serum-related proteins in the respiratory tract secretions of normal mice.

Authors:  J W Osebold; N I Medin; Y C Zee
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

8.  Local immune response in experimental pyelonephritis.

Authors:  J D Lehmann; J W Smith; T E Miller; J A Barnett; J P Sanford
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

9.  Career preferences of first-year students at Canadian medical schools, 1966-67 to 1968-69.

Authors:  R Nelson-Jones; D G Fish
Journal:  Can Med Assoc J       Date:  1970-07-04       Impact factor: 8.262

10.  Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone.

Authors:  W T Butler; R D Rossen
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.